B62	HIV drug resistance patterns among highly treatment-experienced children, adolescents and young adults in sub-Saharan Africa	E-poster	ARV management strategies in paediatric and adolescent populations
B62	The impact of the COVID-19 pandemic on uptake of multi-month dispensing (MMD) of antiretroviral therapy for children living with HIV: a multicountry analysis	E-poster	ARV management strategies in paediatric and adolescent populations
B62	Impact of ARV optimization on HIV viral load suppression among children in Tanzania	E-poster	ARV management strategies in paediatric and adolescent populations
B62	What are the drivers of improved viral suppression among HIV infected children (0-14 years)? Results from the national data warehouse in Kenya 2020	E-poster	ARV management strategies in paediatric and adolescent populations
B33	Efficacy and safety of long-acting subcutaneous lenacapavir in phase 2/3 in heavily treatment-experienced people with HIV: week 26 results (Capella study)	Oral abstract session with live Q&A	ART in highly treatment-experienced people
B33	Transition to TLD leads to decreased rates of virologic failure among PLWH in sub-Saharan Africa	E-poster	ART in highly treatment-experienced people
B33	Long-term (96-week) safety of fostemsavir (FTR) in heavily treatment-experienced (HTE) adults infected with multidrug-resistant (MDR) HIV-1 (BRIGHTE Phase 3 study)	E-poster	ART in highly treatment-experienced people
B33	Weight changes in HIV+ individuals receiving ibalizumab over 96 weeks	E-poster	ART in highly treatment-experienced people
B33	Clinical impact of antiretroviral agents used in optimized background therapy with fostemsavir in heavily treatment-experienced adults with HIV-1: exploratory analyses of the phase 3 BRIGHTE study	E-poster	ART in highly treatment-experienced people
B33	Aggregating loss to follow-up behavior in Patients Living with HIV: a cluster analysis using unsupervised machine learning algorithm in R	E-poster	ART in highly treatment-experienced people